Oric Pharmaceuticals (ORIC) Change in Acquisitions & Divestments (2021 - 2026)

Oric Pharmaceuticals' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $60.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 31.43% year-over-year to $60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225.0 million (down 27.42% YoY) and the FY2025 annual result came in at $252.5 million, down 8.26% from the prior year.
• Change in Acquisitions & Divestments was $60.0 million for Q1 2026 at Oric Pharmaceuticals, down from $62.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $87.5 million in Q1 2025 and bottomed at $10.0 million in Q1 2022.
• A 5-year average of $57.2 million and a median of $58.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 84.85% — and 2023, when it soared 464.75%.
• Oric Pharmaceuticals' Change in Acquisitions & Divestments stood at $60.2 million in 2022, then declined by 16.99% to $50.0 million in 2023, then soared by 55.03% to $77.5 million in 2024, then slipped by 19.35% to $62.5 million in 2025, then decreased by 4.0% to $60.0 million in 2026.
• Business Quant data shows ORIC's Change in Acquisitions & Divestments at $60.0 million in Q1 2026, $62.5 million in Q4 2025, and $55.0 million in Q3 2025.